Edition:
United Kingdom

People: China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

0512.HK on Hong Kong Stock

4.39HKD
19 Jun 2019
Change (% chg)

HK$0.14 (+3.29%)
Prev Close
HK$4.25
Open
HK$4.35
Day's High
HK$4.45
Day's Low
HK$4.28
Volume
502,000
Avg. Vol
2,053,206
52-wk High
HK$5.95
52-wk Low
HK$3.26

Liu, Chengwei 

Mr. Liu Chengwei is the Executive Chairman of the Board of China Grand Pharmaceutical and Healthcare Holdings Ltd. Mr Liu is the Chairman of the Company and is a director of Grand Pharm (China), the principal subsidiary of the Company. Mr Liu is also a director of Huadong Medicine Company Limited, the shares of which are listed on the main board of the Shenzhen Stock Exchange. Mr Liu has over 10 years of financial and management experience in the PRC. Mr Liu is currently the General Manager of the Pharmaceutical Industry Division of China Grand Enterprises Incorporation (“China Grand”) and a director of China Grand. Mr Liu worked for General Electric Company’s China subsidiaries for 5 years before joining China Grand in 2001. Mr Liu holds a bachelor degree in International Economics from Peking University and a master degree in Business Administration from China Europe International Business School.

Basic Compensation

Total Annual Compensation, HKD 50,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD --
Fiscal Year Total, HKD 50,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Chengwei Liu

50,000

Yan Shao

1,516,000

Bo Hu

50,000

Zhanqi Niu

--

Yonghua Feng

--

Xiaofeng Shi

--
As Of  31 Dec 2014